IL116026A - Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses - Google Patents

Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses

Info

Publication number
IL116026A
IL116026A IL11602695A IL11602695A IL116026A IL 116026 A IL116026 A IL 116026A IL 11602695 A IL11602695 A IL 11602695A IL 11602695 A IL11602695 A IL 11602695A IL 116026 A IL116026 A IL 116026A
Authority
IL
Israel
Prior art keywords
domain
gap
linking
preparation
pct
Prior art date
Application number
IL11602695A
Other languages
English (en)
Other versions
IL116026A0 (en
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9413955A external-priority patent/FR2727116B1/fr
Priority claimed from FR9505753A external-priority patent/FR2734266B1/fr
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL116026A0 publication Critical patent/IL116026A0/xx
Publication of IL116026A publication Critical patent/IL116026A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706Guanosine triphosphatase activating protein, GAP
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11602695A 1994-11-22 1995-11-16 Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses IL116026A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9413955A FR2727116B1 (fr) 1994-11-22 1994-11-22 Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
FR9505753A FR2734266B1 (fr) 1995-05-16 1995-05-16 Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation

Publications (2)

Publication Number Publication Date
IL116026A0 IL116026A0 (en) 1996-01-31
IL116026A true IL116026A (en) 2005-08-31

Family

ID=26231549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11602695A IL116026A (en) 1994-11-22 1995-11-16 Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses

Country Status (18)

Country Link
US (1) US5886150A (da)
EP (1) EP0793721B1 (da)
JP (2) JPH10509044A (da)
AT (1) ATE305037T1 (da)
AU (1) AU713937B2 (da)
BR (1) BR9510067A (da)
CA (1) CA2204438A1 (da)
CZ (1) CZ292538B6 (da)
DE (1) DE69534471T2 (da)
DK (1) DK0793721T3 (da)
ES (1) ES2248800T3 (da)
FI (1) FI972170L (da)
HU (1) HU221410B1 (da)
IL (1) IL116026A (da)
MX (1) MX9703364A (da)
NO (1) NO972313L (da)
SK (1) SK287034B6 (da)
WO (1) WO1996016169A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780062B1 (fr) * 1998-06-17 2000-07-28 Rhone Poulenc Rorer Sa Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
MEP42108A (en) * 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
ATE428116T1 (de) * 2000-06-16 2009-04-15 Rudel Thomas Dr Verfahren zur identifizierung wahrend der apoptose modifizierter proteine
US7846746B2 (en) * 2001-04-10 2010-12-07 Children's Medical Center Corporation Methods of analysis and labeling of protein-protein interactions
WO2003006060A1 (en) * 2001-07-09 2003-01-23 Kyowa Hakko Kogyo Co., Ltd. Sh3 domain binding inhibitors
US20050069999A1 (en) * 2001-07-09 2005-03-31 Sharma Sreenath V Sh3 domain binding inhibitors
AUPR721101A0 (en) * 2001-08-23 2001-09-13 University Of Queensland, The Nucleic acid and polypeptide linked to breast cancer
US8143380B2 (en) * 2004-07-08 2012-03-27 Amgen Inc. Therapeutic peptides
WO2006036834A2 (en) * 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
US11237168B2 (en) 2019-06-26 2022-02-01 St. Jude Children's Research Hospital Method for identifying modulators of G3BP activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
ATE181332T1 (de) * 1989-08-21 1999-07-15 Chiron Corp Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung
CA2057675A1 (en) * 1990-12-24 1992-06-25 Michael D. Schaber Peptide inhibitors of ras-gap interaction
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
AU6083894A (en) * 1993-01-15 1994-08-15 Schering Corporation Ras associated gap proteins

Also Published As

Publication number Publication date
CZ292538B6 (cs) 2003-10-15
SK62997A3 (en) 1998-02-04
HUT77029A (hu) 1998-03-02
AU713937B2 (en) 1999-12-16
DE69534471T2 (de) 2006-06-22
US5886150A (en) 1999-03-23
MX9703364A (es) 1997-08-30
HU221410B1 (en) 2002-09-28
FI972170A7 (fi) 1997-05-21
ES2248800T3 (es) 2006-03-16
FI972170A0 (fi) 1997-05-21
JP2006122049A (ja) 2006-05-18
JPH10509044A (ja) 1998-09-08
SK287034B6 (sk) 2009-10-07
DK0793721T3 (da) 2006-01-30
EP0793721A1 (fr) 1997-09-10
FI972170L (fi) 1997-05-21
DE69534471D1 (de) 2006-02-02
ATE305037T1 (de) 2005-10-15
CZ154597A3 (en) 1997-10-15
IL116026A0 (en) 1996-01-31
NO972313D0 (no) 1997-05-21
BR9510067A (pt) 1997-12-30
CA2204438A1 (fr) 1996-05-30
AU4263696A (en) 1996-06-17
NO972313L (no) 1997-05-21
WO1996016169A1 (fr) 1996-05-30
EP0793721B1 (fr) 2005-09-21

Similar Documents

Publication Publication Date Title
AU3368497A (en) Human dnase i hyperactive variants
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
IL116026A (en) Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
AU7617796A (en) Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
MX9806041A (es) Proteina purificada sr-p70.
PT1141305E (pt) Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum
ZA978503B (en) Vertebrate smoothened proteins
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
CA2287902A1 (en) Isolated nucleic acid molecules encoding ssx family members and uses thereof
ZA961419B (en) Human DNase I variants.
SE9604439D0 (sv) New receptor
GB2329896A (en) Enzyme and DNA sequence encoding same
BG101847A (bg) Варианти на човешка дезоксирибонуклеаза i

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees